The Centers for Medicare & Medicaid Services late today announced final changes to the Medicare Advantage and Part D prescription drug programs for 2016, which will increase payments by a net 1.25%, on average. CMS had proposed reducing payments by an average of 0.95%. When combined with expected growth in plan risk scores due to coding, CMS said today’s changes will increase revenue for MA plans and Part D sponsors by an average 3.25%. Among other policy changes, CMS reiterates and clarifies existing rules requiring Medicare Advantage organizations to maintain accurate provider network directories for enrollees. CMS did not finalize its proposal to reduce the weight of seven measures in its star rating system to counterbalance the lack of socioeconomic adjustments but reaffirmed its commitment to further study the issue. For more, see the CMS factsheet

Related News Articles

Headline
Baxter Healthcare Corp., in coordination with the Food and Drug Administration, has agreed to temporarily import certain intravenous drug products, such…
Headline
President Trump yesterday named Eric Hargan as Acting Secretary of Health and Human Services. Confirmed as HHS deputy secretary last week, Hargan previously…
Headline
Hospitals generally support the proposed cancellation of the cardiac and Surgical Hip and Femur Fracture Treatment bundling program and Comprehensive Care for…
Headline
Twenty-three organizations, including the AHA, Friday urged the Centers for Medicare & Medicaid Services to suspend implementation of new draft Medicare…
Headline
More than 20 years ago, Cincinnati Children’s Hospital Medical Center nurse Erin Riehle came up with a novel idea for addressing her hospital’s…
Headline
The Centers for Medicare & Medicaid Services has identified the first clinicians eligible to participate in 2018 advanced alternative payment models, based…